share_log

Eledon Pharma Analyst Ratings

Benzinga ·  Nov 13, 2023 20:45
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/13/2023 1011.11% HC Wainwright & Co. → $13 Reiterates Buy → Buy
10/24/2023 1011.11% HC Wainwright & Co. $25 → $13 Maintains Buy
09/27/2023 754.7% Noble Capital Markets → $10 Initiates Coverage On → Outperform
08/22/2023 669.23% Cantor Fitzgerald → $9 Reiterates Overweight → Overweight
05/26/2023 2036.75% HC Wainwright & Co. → $25 Reiterates Buy → Buy
06/01/2022 2122.22% SVB Leerink $33 → $26 Maintains Outperform
11/24/2021 2036.75% HC Wainwright & Co. $35 → $25 Maintains Buy
04/27/2021 2720.51% SVB Leerink $34 → $33 Maintains Outperform
03/23/2021 2036.75% Cantor Fitzgerald → $25 Initiates Coverage On → Overweight
02/08/2021 2805.98% SVB Leerink → $34 Initiates Coverage On → Outperform

What is the target price for Eledon Pharma (ELDN)?

The latest price target for Eledon Pharma (NASDAQ: ELDN) was reported by HC Wainwright & Co. on November 13, 2023. The analyst firm set a price target for $13.00 expecting ELDN to rise to within 12 months (a possible 1011.11% upside). 5 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Eledon Pharma (ELDN)?

The latest analyst rating for Eledon Pharma (NASDAQ: ELDN) was provided by HC Wainwright & Co., and Eledon Pharma reiterated their buy rating.

When is the next analyst rating going to be posted or updated for Eledon Pharma (ELDN)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eledon Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eledon Pharma was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.

Is the Analyst Rating Eledon Pharma (ELDN) correct?

While ratings are subjective and will change, the latest Eledon Pharma (ELDN) rating was a reiterated with a price target of $0.00 to $13.00. The current price Eledon Pharma (ELDN) is trading at is $1.17, which is within the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment